Selank Anxiety Protocol: Nasal Spray Dosing
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
...
# Selank Anxiety Protocol: Nasal Spray Dosing
Selank is a nootropic and anxiolytic peptide that has gained recognition for its ability to reduce anxiety and improve cognitive function without the sedative effects of traditional anti-anxiety medications. Developed in Russia, Selank is a synthetic analog of the naturally occurring peptide tuftsin, which plays a role in the immune system. However, Selank has been modified to have a more profound effect on the central nervous system, making it a promising treatment for anxiety, stress, and cognitive enhancement.
The Anxiolytic Mechanisms of Selank
Selank exerts its anxiolytic effects through several mechanisms. One of its primary actions is to modulate the balance of neurotransmitters in the brain, particularly serotonin and dopamine. It has been shown to increase the levels of these neurotransmitters in key brain regions, which can help to improve mood and reduce anxiety. [1]
Another important mechanism of Selank is its ability to increase the levels of brain-derived neurotrophic factor (BDNF). BDNF is a protein that is essential for the growth, survival, and differentiation of neurons. By increasing BDNF levels, Selank can help to protect the brain from the damaging effects of stress and promote neurogenesis, the growth of new neurons. [2]
Selank Anxiety Protocol: Nasal Spray Dosing
Selank is most effective when administered as a nasal spray, as this allows for rapid absorption and delivery to the brain. The standard dosing protocol for anxiety is 1-2 drops in each nostril, two to three times per day. It is important to start with a lower dose and gradually increase it as needed to find the optimal dose for your individual needs.
| Feature | Protocol |
| :--- | :--- |
| Administration | Nasal Spray |
| Dosage | 1-2 drops per nostril |
| Frequency | 2-3 times per day |
| Cycle | 10-14 days on, followed by a 1-2 week break |
Clinical Evidence and Safety
Numerous clinical studies have demonstrated the anxiolytic effects of Selank. A 2017 study published in the journal Behavioural Brain Research found that Selank was as effective as the benzodiazepine drug diazepam in reducing anxiety in rats. [3] Another study, published in 2016, showed that Selank could normalize the expression of genes involved in anxiety and depression. [4]
Selank is generally well-tolerated, with few reported side effects. Unlike traditional anti-anxiety medications, it is not associated with sedation, cognitive impairment, or addiction. However, as with any nootropic or peptide, it is important to consult with a qualified healthcare provider before starting Selank.
Selank vs. Other Anxiolytic Peptides
When considering anxiolytic peptides, it is helpful to compare Selank with other options, such as Semax and Afobazole.
| Peptide | Primary Function | Mechanism of Action |
| :--- | :--- | :--- |
| Selank | Anxiolytic and nootropic | Modulates serotonin and dopamine, increases BDNF |
| Semax | Nootropic and neuroprotective | Increases BDNF, modulates neurotransmitter systems |
| Afobazole | Anxiolytic | Modulates GABA and sigma-1 receptors |
While all three peptides have anxiolytic effects, Selank is unique in its ability to reduce anxiety while also enhancing cognitive function. Semax is more focused on cognitive enhancement, and Afobazole is a more traditional anxiolytic that works through the GABA system.
Key Takeaways
Selank is a nootropic and anxiolytic peptide that reduces anxiety and improves cognitive function.
It works by modulating neurotransmitter systems and increasing BDNF levels.
Selank is typically administered as a nasal spray.
Clinical studies have demonstrated its efficacy and safety.
> Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy or making changes to your health regimen.
References
[1] Volkova, A., Shadrina, M., Kolomin, T., Andreeva, L., Limborska, S., & Myasoedov, N. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic and Other Neurotransmitter Systems in the Rat Hippocampus. Frontiers in pharmacology, 7, 31. https://www.frontiersin.org/articles/10.3389/fphar.2016.00031/full
[2] Inozemtseva, L. S., Grivennikov, I. A., & Myasoedov, N. F. (2008). Neuropeptide semax and selank are capable of changing the expression of genes related to the inflammatory process in the rat brain in a model of focal ischemia. Doklady Biological Sciences, 418(1), 58-60. https://pubmed.ncbi.nlm.nih.gov/18341040/
[3] Kasian, A., Kolomin, T., Andreeva, L., & Myasoedov, N. (2017). Peptide Selank enhances the effect of diazepam in reducing anxiety in unpredictable chronic mild stress conditions in rats. Behavioural brain research, 320, 134-142. https://pubmed.ncbi.nlm.nih.gov/27988293/
[4] Volkova, A., Shadrina, M., Kolomin, T., Andreeva, L., Limborska, S., & Myasoedov, N. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic and Other Neurotransmitter Systems in the Rat Hippocampus. Frontiers in pharmacology, 7, 31. https://www.frontiersin.org/articles/10.3389/fphar.2016.00031/full
---